Femasys Inc. (FEMY) vs NexGel, Inc. (NXGL)
Femasys Inc. and NexGel, Inc. are both Medical Instruments & Supplies companies. Femasys Inc. is the larger, with a market value of $20.4M against $3.0M — 6.9× the size. Femasys Inc. grew revenue faster over the last twelve months: 21.9% against 3.38%. NexGel, Inc. has the higher net margin (−51.3% vs −534.3%) and the higher return on invested capital (−45.3% vs −176.9%). Across the 18 metrics below, NexGel, Inc. leads on 12 and Femasys Inc. on 6.
Valuation
Profitability
| Metric | FEMY | NXGL | Medical Instruments & Supplies median |
|---|---|---|---|
| Gross margin | 60.95% | 35.08% | 54.62% |
| Operating margin | (763.90%) | (44.77%) | 1.64% |
| Net margin | (534.27%) | (51.26%) | 0.00% |
| Free cash flow margin | (786.02%) | (27.66%) | 1.61% |
| Return on equity | (443.65%) | (117.57%) | 0.00% |
| Return on assets | (94.25%) | (34.21%) | 0.00% |
| Return on invested capital | (176.91%) | (45.29%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack